Imagen de Portada

Expression and prognostic potential of osteopontin splice variants in malignant melanoma

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Gabriela Ribeiro Silva, Luciana Bueno Ferreira, Etel Rodrigues Pereira Gimba
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Clinical and Translational Science
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Macrophage Cluster of Differentiation 163 promotes post‐infarction cardiac repair and preserves left ventricular function via osteopontin
por: Jingyu Chen, et al.
Publicado: (2026)

Prevalence of actionable pharmacogenetic variants and high‐risk drug prescriptions: A Swiss hospital‐based cohort study
por: Flavia Hodel, et al.
Publicado: (2024)

Randomized evaluation of the loss‐of‐function carboxylesterase 1 (CES1) G143E variant on clopidogrel and ticagrelor pharmacodynamics
por: Joshua P. Lewis, et al.
Publicado: (2024)

Colonic Tissue Expression of MAdCAM ‐1 Is Not Predictive of Vedolizumab Responsiveness in Inflammatory Bowel Disease
por: Nikhil Reddy, et al.
Publicado: (2025)

A comprehensive Thai pharmacogenomics database (TPGxD‐1): Phenotype prediction and variants identification in 942 whole‐genome sequencing data
por: Shobana John, et al.
Publicado: (2024)

The effect of genetic variants in the transcription factor TSPYL family on the CYP3A4 mediated cyclosporine metabolism in kidney transplant patients
por: Qinglian Zhai, et al.
Publicado: (2024)

CEACAM6: A potential prognostic biomarker and therapeutic target in cholangiocarcinoma
por: Jia‐Qi Guo, et al.
Publicado: (2026)

Evaluation of potential drug–drug interactions with medical cannabis
por: Jessie Jia Yi Ho, et al.
Publicado: (2024)

Thai pharmacogenomics database −2 (TPGxD‐2) sequel to TPGxD‐1, analyzing genetic variants in 26 non‐VIPGx genes within the Thai population
por: Shobana John, et al.
Publicado: (2024)

Plasma sCD146 is a potential biomarker for acute exacerbation of chronic obstructive pulmonary disease
por: Xinyu Jia, et al.
Publicado: (2024)

Drug Interaction PBPK Modeling: Review of the Literature Exposes the Need for Increased Verification of Model Inputs and Outputs as Part of Credibility Assessment
por: David Rodrigues, et al.
Publicado: (2025)

Predictors of potential clinically harmful drug–drug interactions at the medical wards in the University of Benin Teaching Hospital, Benin City
por: Oseremen Godstime Oriaifo, et al.
Publicado: (2024)

Long‐term benefit of SGLT2 inhibitors to prevent heart failure hospitalization in patients with diabetes, with potential time‐varying benefit
por: Yasuo Takahashi, et al.
Publicado: (2024)

Can Environmental Enrichment Mitigate Cell Apoptosis in the Central Nervous System Under Adverse Health Conditions? A Systematic Review
por: Matheus Santos de Sousa Fernandes, et al.
Publicado: (2026)

Proposing a framework to quantify the potential impact of pharmacokinetic drug–drug interactions caused by a new drug candidate by using real world data about the target patient population
por: Simon Dagenais, et al.
Publicado: (2024)

Clinical pharmacokinetics and pharmacodynamics of ongericimab: A potential long‐acting PCSK9 monoclonal antibody in healthy subjects and patients with hypercholesterolemia: Randomized, double‐blind, placebo‐controlled phase Ia and Ib/II studies
por: Juanjuan Jiang, et al.
Publicado: (2024)

The Role of Candidate Polymorphisms in Drug Transporter Genes on High‐Dose Methotrexate in the Consolidation Phase of the AIEOP‐BFM ALL 2009 Protocol
por: Stefania Braidotti, et al.
Publicado: (2025)

Inhibition of Tacrolimus Metabolism by Cannabidiol and Its Metabolites In Vitro
por: Gerald C. So, et al.
Publicado: (2025)

Splicing to keep splicing: A feedback system for cellular homeostasis and state transition
por: Zhonghao Guo, et al.
Publicado: (2025)

Genotype–Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers
por: Jumar Etkins, et al.
Publicado: (2025)

Bioavailability of a novel sustained‐release pellet formulation of 5‐flucytosine in healthy‐fed participants for use in patients with cryptococcal meningitis
por: Nabila Ibnou Zekri Lassout, et al.
Publicado: (2024)

Pharmacokinetics and safety of erenumab in pediatric patients with migraine: A phase I, randomized, open‐label, multiple‐dose study
por: Andrew D. Hershey, et al.
Publicado: (2024)

Pan‐cancer analyses of bromodomain containing 9 as a novel therapeutic target reveals its diagnostic, prognostic potential and biological mechanism in human tumours
por: Yu Chen, et al.
Publicado: (2024)

Lymphocyte activation gene 3 served as a potential prognostic and immunological biomarker across various cancer types: a clinical and pan‐cancer analysis
por: Yifan Liu, et al.
Publicado: (2024)

Overcoming challenges in CAR‐T therapy for malignancies: Mechanisms and strategies
por: Yushan Huang, et al.
Publicado: (2026)

RNA splicing factor RBFOX2 is a key factor in the progression of cancer and cardiomyopathy
por: Jinze Shen, et al.
Publicado: (2024)

A new metabolic signature to predict melanoma recurrence
por: Ngan K. Vu, et al.
Publicado: (2024)

Non‐m6A RNA modifications in haematological malignancies
por: Meiling Chen, et al.
Publicado: (2024)

Exporting nuclear export inhibitors from hematologic to solid tumour malignancies
por: Alexandra Chirino, et al.
Publicado: (2024)

Single‐cell landscape of the tumour immune microenvironment in human gynaecologic malignancies
por: Simin Yin, et al.
Publicado: (2025)

Dynamics of the intratumoural microbiome across malignant transformation and treatment in breast cancer
por: Liuliu Quan, et al.
Publicado: (2025)

Erratum for the “S100A7 as a potential diagnostic and prognostic biomarker of esophageal squamous cell carcinoma promotes M2 macrophage infiltration and angiogenesis” by Zhiliang Lu et al.
Publicado: (2025)

Distant metastases of melanoma exhibit varying extent of intrapatient proteogenomic heterogeneity
por: Beata Szeitz, et al.
Publicado: (2025)

Current advances in the role of classical non‐homologous end joining in hematologic malignancies
por: Pengcheng Liu, et al.
Publicado: (2025)

Pharmacogenomic variation and sedation outcomes during early intensive care unit admission: A pragmatic study
por: Moataz E. Mohamed, et al.
Publicado: (2024)

Rapid identification and phenotyping of nonalcoholic fatty liver disease patients using a machine‐based approach in diverse healthcare systems
por: Anna O. Basile, et al.
Publicado: (2024)

Translational findings support regimen selection for first‐in‐human study of ubamatamab (MUC16 × CD3 bispecific antibody) in patients with recurrent ovarian cancer
por: Min Zhu, et al.
Publicado: (2024)

Quantification of SARS‐CoV‐2 viral load in patients using time‐to‐results in antigen lateral flow tests
por: Elsa W. Braunstein, et al.
Publicado: (2024)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral allosteric TYK2 inhibitor ESK‐001 using a randomized, double‐blind, placebo‐controlled study design
por: Sibel Ucpinar, et al.
Publicado: (2024)

QPGx‐CARES: Qatar pharmacogenetics clinical applications and research enhancement strategies
por: Rania Abdel‐latif, et al.
Publicado: (2024)